Skip to content

Antimicrobial effects of Silver Diamine Fluoride compared to Chlorhexidine

Antimicrobial effects of treatment with Silver Diamine Fluoride compared to Chlorhexidine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3kjjc4
Enrollment
Unknown
Registered
2018-10-16
Start date
2018-09-21
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental caries

Interventions

Group 1: 10 Restorations with glass ionomer cement previously using Chlorhexidine as an antimicrobial agent
Group 2: 10 Glass ionomer cement restorations previously using 30% Diamino Fluoride Silver as an antimicrobial agent
Group 3: 10 Restorations with glass ionomer cement previously using 38% Silver Diamino Fluoride as an antimicrobial agent
Group 4: 10 Restorations with glass ionomer cement without an antimicrobial agent.
Drug
E06.323.428

Sponsors

Universidade de Brasília
Lead Sponsor
Universidade de Brasília
Collaborator

Eligibility

Age
7 Years to 10 Years

Inclusion criteria

Inclusion criteria: Patients who present at least one active carious lesion in deciduous molar located in the external half of the dentin, without pulpal or periodontal disease; Both sexes; Age range: 7 to 10 years.

Exclusion criteria

Exclusion criteria: Children whose parents did not sign the Informed Consent Form; Children who did not assent to participate in the study; Children who had some type of systemic impairment and/or special needs throughout treatment.

Design outcomes

Primary

MeasureTime frame
Primary outcome: reduction of bacterial count (CFU) in carious dentin after application of different antimicrobial agents.

Secondary

MeasureTime frame
Secondary outcomes are not expected

Countries

Brazil

Contacts

Public ContactÉrica Piovesan

Universidade de Brasília

ericatorresa@hotmail.com61 99119-7061

Outcome results

None listed

Source: REBEC (via WHO ICTRP)